Boston Scientific Corporation (BSX)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 11:24AM EDT. Market open.
| Previous close | 72.21 |
| Open | 72.47 |
| Bid | 71.56 x 1400 |
| Ask | 71.58 x 3000 |
| Day's range | 70.97 - 72.56 |
| 52-week range | 48.35 - 74.39 |
| Volume | |
| Avg. volume | 6,378,427 |
| Market cap | 105.054B |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | 60.06 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
BD (BDX) Q2 Earnings Surpass Estimates, FY24 View Revised
BD's (BDX) overall top line benefits from revenue growth in all segments and both geographic regions in the fiscal second quarter.
- Zacks
Accuray (ARAY) Q3 Earnings Lag Estimates, Gross Margin Contracts
Despite strength in radiation oncology, Accuray (ARAY) reports dismal third-quarter fiscal 2024 results.
- Zacks
Glaukos (GKOS) Q1 Earnings Miss Estimates, Revenues Up Y/Y
Glaukos' (GKOS) first-quarter 2024 results showcase growth in revenues while earnings miss the Zacks consensus Estimate. Loss at the operating level raises concern as well.
© 2024 Yahoo. All rights reserved.